批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/06/05 |
SUPPL-59(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/07/29 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/10/25 |
SUPPL-46(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/07/11 |
SUPPL-44(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1999/09/07 |
SUPPL-43(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/12/01 |
SUPPL-42(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/06/16 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/06/12 |
SUPPL-39(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/05/07 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/02/15 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
1995/01/05 |
SUPPL-36(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1994/01/27 |
SUPPL-34(补充) |
Approval |
Labeling |
|
|
|
1992/08/28 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/12/31 |
SUPPL-32(补充) |
Approval |
Labeling |
|
|
|
1991/10/28 |
SUPPL-31(补充) |
Approval |
Labeling |
|
|
|
1991/06/12 |
SUPPL-29(补充) |
Approval |
Labeling |
|
|
|
1991/06/12 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/10/05 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/03/15 |
SUPPL-26(补充) |
Approval |
Labeling |
|
|
|
1989/02/17 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
1988/09/07 |
SUPPL-24(补充) |
Approval |
Labeling |
|
|
|
1988/01/11 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/01/11 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/01/11 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/10/22 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1984/12/07 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1983/02/17 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1983/02/17 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1975/07/15 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:DEXAMETHASONE SODIUM PHOSPHATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 4MG PHOSPHATE/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
084282 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
084916 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
FRESENIUS KABI USA |
040803 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2008/08/29
|
MYLAN LABS LTD |
203129 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2015/09/30
|
FRESENIUS KABI USA |
206781 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2015/12/01
|
EUGIA PHARMA |
207521 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2018/06/08
|
SOMERSET |
208689 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2018/08/22
|
AMNEAL |
215654 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Prescription |
No |
No |
AP |
2021/08/04
|
GLAND PHARMA LTD |
211451 |
001 |
ANDA |
DEXAMETHASONE SODIUM PHOSPHATE |
DEXAMETHASONE SODIUM PHOSPHATE |
INJECTABLE;INJECTION |
EQ 4MG PHOSPHATE/ML |
Discontinued |
No |
No |
AP |
2023/08/01
|
HIKMA |